Baliquig, Rica Ann G.
HRN: 18-79-27 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/26/2023
CEFUROXIME 750MG (VIAL)
07/26/2023
08/02/2023
IV
400mg
Q8
UTI
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes